BioInvent International

16,76SEK +1,21 %
1 investor følger denne virksomhed

BioInvent International is active in the pharmaceutical industry. The company focuses on the research and development of antibody drugs used in the treatment of cancer. The company has its own development platform and collaborations take place via the company's partners. In the early development phase, the company is working to recreate the disease biology to get indications about the substance's effect on the disease. The head office is located in Lund, Sweden.

Omsætning
326,13 mio.
EBIT %
-15,61 %
P/E
-
Udbytteafkast, %
-
Kursmål
-
Anbefaling
-
Opdateret
-
NASDAQ Stockholm
BINV
Daglig lav / høj pris
16,56 / 16,92 SEK
Markedsværdi
1,1 mia. SEK
Aktieomsætning
358,76 t SEK
Volumen
21 t

Major Owners
Source: Millistream Market Data AB

OwnerCapitalVotes
Redmile Group, LLC15,4 %15,4 %
Van Herk Investments10,1 %10,1 %
Premium
Not activated

This content is for our Premium customers only.